Eribulin for recurrent cutaneous angiosarcoma
Linked Article: Fujisawa et al. Br J Dermatol 2020; 183:831–839.
Gespeichert in:
| Veröffentlicht in: | British journal of dermatology (1951) 2020-11, Vol.183 (5), p.797-798 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 798 |
|---|---|
| container_issue | 5 |
| container_start_page | 797 |
| container_title | British journal of dermatology (1951) |
| container_volume | 183 |
| creator | Smrke, A. Benson, C. |
| description | Linked Article: Fujisawa et al. Br J Dermatol 2020; 183:831–839. |
| doi_str_mv | 10.1111/bjd.19333 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2427523246</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2427523246</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3533-99cf703c42099479f44cef5d91fcf87d38723dce3f601358b0650c398ba2ffff3</originalsourceid><addsrcrecordid>eNp10DtPwzAUBWALgWh5DPwBFIkFhrTXvnZcj1DKS5VYYLYSx0ap8ih2I9R_jyGFAYm73OXT0dEh5IzChMabFqtyQhUi7pExxUykjCLukzEAyBRUhiNyFMIKgCIIOCQjZJJmwNWYpAtfFX1dtYnrfOKt6b237SYx_SZvbdeHJG_fqi7k3nRNfkIOXF4He7r7x-T1bvEyf0iXz_eP8-tlalAgpkoZJwENZ6AUl8pxbqwTpaLOuJkscSYZlsaiy2IlMSsgE2BQzYqcuXh4TC6H3LXv3nsbNrqpgrF1PXTSjDMpGDKeRXrxh6663rexXVQiQ8lA8qiuBmV8F4K3Tq991eR-qynorw113FB_bxjt-S6xLxpb_sqf0SKYDuCjqu32_yR983Q7RH4CJ9942w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2456372074</pqid></control><display><type>article</type><title>Eribulin for recurrent cutaneous angiosarcoma</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Smrke, A. ; Benson, C.</creator><creatorcontrib>Smrke, A. ; Benson, C.</creatorcontrib><description>Linked Article: Fujisawa et al. Br J Dermatol 2020; 183:831–839.</description><identifier>ISSN: 0007-0963</identifier><identifier>EISSN: 1365-2133</identifier><identifier>DOI: 10.1111/bjd.19333</identifier><identifier>PMID: 32716049</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Furans ; Hemangiosarcoma - drug therapy ; Humans ; Ketones ; Neoplasm Recurrence, Local - drug therapy ; Prospective Studies ; Taxoids</subject><ispartof>British journal of dermatology (1951), 2020-11, Vol.183 (5), p.797-798</ispartof><rights>2020 British Association of Dermatologists</rights><rights>Copyright © 2020 British Association of Dermatologists</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3533-99cf703c42099479f44cef5d91fcf87d38723dce3f601358b0650c398ba2ffff3</citedby><cites>FETCH-LOGICAL-c3533-99cf703c42099479f44cef5d91fcf87d38723dce3f601358b0650c398ba2ffff3</cites><orcidid>0000-0002-9811-8159</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fbjd.19333$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fbjd.19333$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32716049$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Smrke, A.</creatorcontrib><creatorcontrib>Benson, C.</creatorcontrib><title>Eribulin for recurrent cutaneous angiosarcoma</title><title>British journal of dermatology (1951)</title><addtitle>Br J Dermatol</addtitle><description>Linked Article: Fujisawa et al. Br J Dermatol 2020; 183:831–839.</description><subject>Furans</subject><subject>Hemangiosarcoma - drug therapy</subject><subject>Humans</subject><subject>Ketones</subject><subject>Neoplasm Recurrence, Local - drug therapy</subject><subject>Prospective Studies</subject><subject>Taxoids</subject><issn>0007-0963</issn><issn>1365-2133</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10DtPwzAUBWALgWh5DPwBFIkFhrTXvnZcj1DKS5VYYLYSx0ap8ih2I9R_jyGFAYm73OXT0dEh5IzChMabFqtyQhUi7pExxUykjCLukzEAyBRUhiNyFMIKgCIIOCQjZJJmwNWYpAtfFX1dtYnrfOKt6b237SYx_SZvbdeHJG_fqi7k3nRNfkIOXF4He7r7x-T1bvEyf0iXz_eP8-tlalAgpkoZJwENZ6AUl8pxbqwTpaLOuJkscSYZlsaiy2IlMSsgE2BQzYqcuXh4TC6H3LXv3nsbNrqpgrF1PXTSjDMpGDKeRXrxh6663rexXVQiQ8lA8qiuBmV8F4K3Tq991eR-qynorw113FB_bxjt-S6xLxpb_sqf0SKYDuCjqu32_yR983Q7RH4CJ9942w</recordid><startdate>202011</startdate><enddate>202011</enddate><creator>Smrke, A.</creator><creator>Benson, C.</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9811-8159</orcidid></search><sort><creationdate>202011</creationdate><title>Eribulin for recurrent cutaneous angiosarcoma</title><author>Smrke, A. ; Benson, C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3533-99cf703c42099479f44cef5d91fcf87d38723dce3f601358b0650c398ba2ffff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Furans</topic><topic>Hemangiosarcoma - drug therapy</topic><topic>Humans</topic><topic>Ketones</topic><topic>Neoplasm Recurrence, Local - drug therapy</topic><topic>Prospective Studies</topic><topic>Taxoids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Smrke, A.</creatorcontrib><creatorcontrib>Benson, C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of dermatology (1951)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Smrke, A.</au><au>Benson, C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Eribulin for recurrent cutaneous angiosarcoma</atitle><jtitle>British journal of dermatology (1951)</jtitle><addtitle>Br J Dermatol</addtitle><date>2020-11</date><risdate>2020</risdate><volume>183</volume><issue>5</issue><spage>797</spage><epage>798</epage><pages>797-798</pages><issn>0007-0963</issn><eissn>1365-2133</eissn><abstract>Linked Article: Fujisawa et al. Br J Dermatol 2020; 183:831–839.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>32716049</pmid><doi>10.1111/bjd.19333</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-9811-8159</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-0963 |
| ispartof | British journal of dermatology (1951), 2020-11, Vol.183 (5), p.797-798 |
| issn | 0007-0963 1365-2133 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2427523246 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Oxford University Press Journals All Titles (1996-Current) |
| subjects | Furans Hemangiosarcoma - drug therapy Humans Ketones Neoplasm Recurrence, Local - drug therapy Prospective Studies Taxoids |
| title | Eribulin for recurrent cutaneous angiosarcoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T18%3A28%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Eribulin%20for%20recurrent%20cutaneous%20angiosarcoma&rft.jtitle=British%20journal%20of%20dermatology%20(1951)&rft.au=Smrke,%20A.&rft.date=2020-11&rft.volume=183&rft.issue=5&rft.spage=797&rft.epage=798&rft.pages=797-798&rft.issn=0007-0963&rft.eissn=1365-2133&rft_id=info:doi/10.1111/bjd.19333&rft_dat=%3Cproquest_cross%3E2427523246%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2456372074&rft_id=info:pmid/32716049&rfr_iscdi=true |